Autobahn Therapeutics
Restoring hope for people affected by CNS disorders
Our mission is to improve life health for people affected by CNS disorders by driving the regenerative power of the human body
We aim to restore hope for people affected by both rare and prevalent diseases by creating the next generation of regenerative medicines for the brain. By restoring the brain to a healthier state these therapies will address the progressive and debilitating course of these conditions, allowing people to live the futures they deserve.
Our Approach
Leverage validated human biology to de-risk and accelerate programs from discovery to clinic to patients.
Employ our brain-targeting chemistry platform to create a pipeline of transformative small molecule therapies that cross the blood-brain barrier.
Utilize biomarker-driven clinical development strategies to demonstrate on-target / on-tissue activity and proof-of-mechanism early in development.